CYP1A1 and non-small cell lung carcinoma: To investigate the potential role of CYP1A1 A-to-I RNA editing in tumorigenic properties in NSCLC, RNA-seq was performed to compare A549 and A549I462V cells to further elucidate the involvement of CYP1A1 overediting in tumor progression (Fig. 5A).